Henry Hsu

US Patent:

8567098, Oct 29, 2013

Filed:

Mar 19, 2013

Appl. No.:

13/847311

Inventors:

Henry Hsu - Torrance CA, US

International Classification:

A43B 3/24
A43B 3/26

US Classification:

36101, 36 97, 36100

Abstract:

An article of footwear includes a sole and an upper attached to the sole. The sole includes a hard sole base forming an outline of the footwear and a mid sole resting on the sole base, the mid sole made of a softer material than the sole base to provide comfort to a wearer. The upper has sock like construction using stretchable materials to conform to shapes of the foot. The upper is attached to the sole by straps passing through the upper allowing a degree of independent motion of the upper to conform to a foot.

US Patent:

8640363, Feb 4, 2014

Filed:

Mar 19, 2013

Appl. No.:

13/847281

Inventors:

Henry Hsu - Torrance CA, US

International Classification:

A43B 7/14
A43B 3/24
A43B 3/12
A61F 5/14

US Classification:

36145, 36101, 36 115, 36148, 36 76 R

Abstract:

Footwear including an integrated orthotics system provides support with progressive resistance in pronation and supenation motions of the foot during a gait cycle. The orthotics system includes an orthotic device between the mid-sole and the outsole and extend from the rear foot's calcaneus region to the forefoot region where the phalanges and metatarsal joints meets. The orthotic device includes contours mimicking a foot sole shape in an unloaded state. The orthotic system may also include a secondary external orthotic device embedded underneath the outsole to provide control in the mid foot region to achieve progressive compression resistance in the mid foot arch zones. The secondary device may be customizable to achieve a wide range of resistance level needed in mid foot compression by the wearer. The orthotics combined with the midsole and outsole provide progressive mid foot compression resistance and directional flex associated with pronatory motions of the foot.

US Patent:

20040241138, Dec 2, 2004

Filed:

Jun 28, 2004

Appl. No.:

10/483938

Inventors:

Henry Hsu - Hillsborough CA, US

International Classification:

A61K038/21

US Classification:

424/085500

Abstract:

The present invention provides methods of reducing liver fibrosis; methods of increasing liver function in an individual suffering from liver fibrosis; and methods of reducing the incidence of complications associated with cirrhosis of the liver. The methods generally involve administering a therapeutically effective amount of IFN-.

US Patent:

20050013801, Jan 20, 2005

Filed:

Oct 3, 2002

Appl. No.:

10/490457

Inventors:

Henry Hsu - Hillsborough CA, US

International Classification:

A61K038/21

US Classification:

424085500, 424085700

Abstract:

The present invention provides methods of reducing liver fibrosis; methods of increasing liver function in an individual suffering from liver fibrosis; methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver; methods of reducing viral load, and methods of treating an HCV infection. The methods generally involve administering a therapeutically effective amount of IFN-α and IFN-γ concurrently.

US Patent:

20050031585, Feb 10, 2005

Filed:

Sep 20, 2002

Appl. No.:

10/490456

Inventors:

Henry Hsu - Hillsborough CA, US

International Classification:

A61K038/21
A61K031/7056

US Classification:

424085700, 514043000

Abstract:

The present invention provides methods for treating individuals having a hepatitis C virus (HCV) infection, which individuals have failed to respond to therapy with an IFN-α other than consensus interferon (CIFN), or who, following cessation of therapy with an IFN-α other than CIFN, have suffered relapse. The methods generally involve a treatment regimen comprising administering a first dosing regimen of CIFN, followed by a second dosing regimen of CIFN. Ribavirin is administered with at least the second dosing regimen.

US Patent:

20050031586, Feb 10, 2005

Filed:

Sep 24, 2002

Appl. No.:

10/490503

Inventors:

Henry Hsu - Hillsborough CA, US

International Classification:

A61K038/21

US Classification:

424085700

Abstract:

The present invention provides methods for treating individuals having an HCV infection, which individuals have failed to respond to therapy with an INF-α other than consensus interferon (CIFN), or who, following cessation of therapy with an INF-α other than CIFN, have suffered relapse. The methods generally involve a dosage regimen involving administering a dose of CIFN and a dose of ribavirin for a period of time, where the dosage regimen is effective to achieve a sustained viral response in the individual.

US Patent:

20060110358, May 25, 2006

Filed:

Aug 20, 2003

Appl. No.:

10/526087

Inventors:

Henry Hsu - Hillsborough CA, US

International Classification:

A61K 38/21

US Classification:

424085600

Abstract:

The present invention provides methods of treating a fibrotic disorder. The methods generally involve administering an effective amount of IFN-γ and an effective amount of pirfenidone or a pirfenidone analog.

US Patent:

20130163731, Jun 27, 2013

Filed:

Sep 11, 2012

Appl. No.:

13/610771

Inventors:

Steven Kai-Man Yan - San Francisco CA, US
Adrian Peter McDermott - San Francisco CA, US
Henry Hsu - Fremont CA, US

International Classification:

H04M 3/523
G06F 9/44

US Classification:

379 85, 719329, 37926514, 37926502

Abstract:

Techniques for improving customer relationship management are disclosed. The techniques may be realized via a call processing system that may efficiently rout an incoming call to an agent of a call center. Also, the call processing system may provision a telephone number to a web-based help desk call center. Further, the call processing system may include a communication framework enabling a communication between a plurality of browser windows and a local storage medium.